Tumor of Bone Clinical Trials

1 recruiting

Tumor of Bone Trials at a Glance

8 actively recruiting trials for tumor of bone are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Seattle, Los Angeles, and Boston. Lead sponsors running tumor of bone studies include Dana-Farber Cancer Institute, Second Affiliated Hospital, School of Medicine, Zhejiang University, and Blokhin's Russian Cancer Research Center.

Browse tumor of bone trials by phase

Treatments under study

About Tumor of Bone Clinical Trials

Looking for clinical trials for Tumor of Bone? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Tumor of Bone trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Tumor of Bone clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 3

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

Giant Cell Tumor of Bone
St. Louis University120 enrolled16 locationsNCT03295981
Recruiting
Not Applicable

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

Ewing SarcomaPeripheral Primitive Neuroectodermal TumorEwing Sarcoma of Bone+3 more
Dana-Farber Cancer Institute340 enrolled15 locationsNCT06068075
Recruiting
Phase 4

Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery

Giant Cell Tumor of Bone
Shanghai Jiao Tong University Affiliated Sixth People's Hospital40 enrolled1 locationNCT07315828
Recruiting

PROMIS and Mobility Evaluation in Sarcoma Patients

SarcomaGiant Cell Tumor of Bone
University of Calgary800 enrolled4 locationsNCT07227961
Recruiting
Phase 2

Definitive Radiation for High-Risk Spine Metastases

Metastatic Breast CancerMetastatic CancerMetastatic Lung Cancer+5 more
Stony Brook University26 enrolled1 locationNCT06165419
Recruiting
Phase 1Phase 2

Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study

Giant Cell Tumor of Bone
Tang Xiaodong45 enrolled1 locationNCT06647901
Recruiting
Not Applicable

3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors

SurgeryChest Wall TumorSarcoma of Bone+3 more
Blokhin's Russian Cancer Research Center30 enrolled1 locationNCT05057143
Recruiting
Phase 2

Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage

Giant Cell Tumor of Bone
Second Affiliated Hospital, School of Medicine, Zhejiang University153 enrolled1 locationNCT05595603